Protagonist Therapeutics, Inc. ($PTGX)
Filing Information
| Accession Number | 0001104659-26-007129 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 28, 2026 |
| Document Date | Jan 23, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
150,819
Total Value
$4,584,374.36
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 23, 2026 | Gift | 6,000 | $0.00 | $0.00 | 574,505 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 23, 2026 | Exercise/Conversion | 19,315 | $4.21 | $81,316.15 | 593,820 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 23, 2026 | Sale | 19,315 | $84.59 | $1,633,855.85 | 574,505 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 26, 2026 | Exercise/Conversion | 10,685 | $4.21 | $44,983.85 | 585,190 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 26, 2026 | Sale | 10,685 | $84.00 | $897,540.00 | 574,505 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 26, 2026 | Exercise/Conversion | 14,205 | $21.58 | $306,543.90 | 588,710 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 26, 2026 | Sale | 14,205 | $84.05 | $1,193,930.25 | 574,505 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 27, 2026 | Exercise/Conversion | 4,068 | $21.58 | $87,787.44 | 578,573 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 27, 2026 | Sale | 4,068 | $83.19 | $338,416.92 | 574,505 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 23, 2026 | Exercise/Conversion | 19,315 | $0.00 | $0.00 | 10,685 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 26, 2026 | Exercise/Conversion | 10,685 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 26, 2026 | Exercise/Conversion | 14,205 | $0.00 | $0.00 | 304,068 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 27, 2026 | Exercise/Conversion | 4,068 | $0.00 | $0.00 | 300,000 | Direct | โ | View Details |